Citadel Advisors
OCGN icon

Citadel Advisors’s Ocugen OCGN Stock Holding History

Citadel Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
255,700
-58,600
-19% -$89.1K ﹤0.01% 10484
2026
Q1 		$569K Buy
314,300
+89,800
+40% +$155K ﹤0.01% 8989
2025
Q4 		$303K Buy
224,500
+68,200
+44% +$97.1K ﹤0.01% 10128
2025
Q3 		$255K Buy
156,300
+65,700
+73% +$72.8K ﹤0.01% 10715
2025
Q2 		$87.9K Buy
90,600
+67,800
+297% +$56.2K ﹤0.01% 11427
2025
Q1 		$16.1K Sell
22,800
-277,000
-92% -$192K ﹤0.01% 13292
2024
Q4 		$241K Sell
299,800
-49,100
-14% -$45K ﹤0.01% 10102
2024
Q3 		$346K Sell
348,900
-22,400
-6% -$30.7K ﹤0.01% 9032
2024
Q2 		$576K Sell
371,300
-2,500
-0.7% -$3.9K ﹤0.01% 7767
2024
Q1 		$613K Sell
373,800
-88,300
-19% -$74K ﹤0.01% 7939
2023
Q4 		$266K Sell
462,100
-34,600
-7% -$13.9K ﹤0.01% 9397
2023
Q3 		$199K Sell
496,700
-19,500
-4% -$9.63K ﹤0.01% 9927
2023
Q2 		$280K Sell
516,200
-49,300
-9% -$31.6K ﹤0.01% 9198
2023
Q1 		$482K Sell
565,500
-346,100
-38% -$377K ﹤0.01% 8396
2022
Q4 		$1.19M Buy
911,600
+291,800
+47% +$455K ﹤0.01% 6485
2022
Q3 		$1.1M Buy
619,800
+224,000
+57% +$558K ﹤0.01% 6787
2022
Q2 		$898K Sell
395,800
-270,900
-41% -$648K ﹤0.01% 7265
2022
Q1 		$2.2M Buy
666,700
+240,800
+57% +$846K ﹤0.01% 5883
2021
Q4 		$1.94M Sell
425,900
-293,000
-41% -$2.21M ﹤0.01% 6316
2021
Q3 		$5.16M Sell
718,900
-1,266,400
-64% -$9.3M ﹤0.01% 4237
2021
Q2 		$15.9M Buy
1,985,300
+1,647,300
+487% +$13.9M ﹤0.01% 2376
2021
Q1 		$2.29M Buy
+338,000
New +$2.25M ﹤0.01% 6066

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors's OCGN Position: Q2 2026 in Review

Citadel Advisors reduced its Ocugen (OCGN) stake by 72% in Q2 2026, selling an estimated $3.08M and leaving 783,322 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #7764.

Citadel Advisors first reported a position in OCGN in Q1 2017 and has held it in 25 quarters since. The position peaked at $5.49M in Q1 2021. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Citadel Advisors held 783,322 shares of Ocugen worth $1.2M as of Q2 2026.
  • Citadel Advisors sold 2,025,835 Ocugen shares in Q2 2026, an estimated $3.08M.
  • Ocugen made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7764 holding.
  • Citadel Advisors first reported a position in Ocugen in Q1 2017 and has held it in 25 quarters since.
  • Citadel Advisors's Ocugen position peaked at $5.49M in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.